Analyst consensus rating
CalciMedica Analyst Rating: Strong Buy
Direct answer
CalciMedica's consensus rating is Strong Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $38.00.
Forecast evidence checked October 17, 2026.
Get free CalciMedica email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.04
- Average price target
- $38.00
- High price target
- $75.00
- Low price target
- $9.00
- Low target gap
- +765.4%
- Target upside
- +3,553.8%
- High target gap
- +7,111.5%
- Target range width
- 6,346.2%
- Consensus rating
- Strong Buy
- Analysts
- 3
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for CalciMedica?
CalciMedica has a verified Strong Buy consensus. The same dataset has an average price target of $38.00.
How far are CalciMedica's low and high targets from the recorded price?
The low target implies +765.4%, while the high target implies +7,111.5%.
How many analysts are included in CalciMedica's consensus?
The verified consensus includes 3 analysts.
How is CalciMedica's target upside or downside calculated?
The average target of $38.00 is divided by the recorded price of $1.04, then one is subtracted to produce +3,553.8%. This does not guarantee a future return.
When was CalciMedica's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.